Stay updated with breaking news from Nasdaq phat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Get Free Report)’s share price shot up 11.8% during mid-day trading on Monday . The company traded as high as $11.23 and last traded at $11.22. 489,633 shares were traded during trading, a decline of 40% from the average session volume of 809,964 shares. The stock had previously closed at […] ....
Stifel Nicolaus initiated coverage on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued a buy rating and a $24.00 price objective on the stock. Separately, Needham & Company LLC restated a buy rating and set a $26.00 price objective on shares of Phathom […] ....
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a report issued on Friday morning, Benzinga reports. The firm currently has a $26.00 target price on the stock. Separately, Stifel Nicolaus assumed coverage on shares of Phathom Pharmaceuticals in a research report on Friday. They set […] ....
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) will release its earnings data before the market opens on Thursday, May 9th. Analysts expect Phathom Pharmaceuticals to post earnings of ($1.13) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Phathom Pharmaceuticals (NASDAQ:PHAT – Get […] ....
Needham & Company LLC reiterated their buy rating on shares of Phathom Pharmaceuticals (NASDAQ:PHAT – Free Report) in a research note released on Friday, Benzinga reports. They currently have a $26.00 price target on the stock. Phathom Pharmaceuticals Stock Up 1.9 % PHAT stock opened at $9.35 on Friday. The stock has a market capitalization […] ....